Default company panoramic image
6e2d5064 c167 4532 bdb5 332629d63eb0


We are developing new technology which will allow the user to detect lead content in paint using a smart phone.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Edwardsville, IL, USA
  • Currency USD
  • Founded May 2012
  • Employees 2
  • Website

Company Summary

TRL-5 LABS is a R&D firm with expertise in the areas of biotechnology and chemistry. We develop new technologies into commercial products and formulations. We fund initial development through outside sources such as government or commercial clients. We also transition technologies from universities under licensing agreements. We have a patent pending on our first technology, a system for detection of lead in paint.


  • Default avatar
    Joan Stader
    Co-Founder and Managing Partner

    Dr. Stader has been involved in R&D for over 30 years and led numerous multidisciplinary programs in the development of Chem-Bio defense technologies for the government. These programs produced advances in instrument design and prototyping, process development, chemical formulation and testing & evaluation. Dr. Stader also participated in transitioning these technologies into the commercial sector through both manufacturing and licensing.

  • Default avatar
    Charles E Murphree
    Co-Founder and Managing Partner

    Mr. Charles E. Murphree, Jr is the founder and President of the SGBC Group. Mr. Murphree has spent the past 30 years working in the Defense Industry where he has participated in many technology development programs for various Federal Agencies and the Department of Defense. Mr. Murphree technical expertise lies with new product realization and quality function deployment to include product planning, product design, process planning and control.


  • Default avatar
    R. Dan Winnett, Esq.
    Default avatar
    Stephen G. Eovaldi

Previous Investors

  • Default avatar
    National Institutes of Health (SBIR Sponsor)